XINEUR
LIVE

Serial Number

79402685

Owner

KOLINPHARMA S.P.A.

Attorney

Stephanie N. Nikitenko

Filing Date

Dec 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

XINEUR Trademark

Serial Number: 79402685 • Registration: 7683347

XINEUR is a trademark filed by KOLINPHARMA S.P.A. on December 4, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

KOLINPHARMA S.P.A. (7 trademarks)

Via Larga, 8

Entity Type: 99

Trademark Details

Filing Date

December 4, 2023

Registration Date

February 11, 2025

Published for Opposition

December 24, 2024

Goods & Services

Pharmaceuticals, preparations, substances and pharmaceutical products, parapharmaceutical, sanitary and hygienic preparations, namely orthopaedic, osteoarticular, gynaecological, urological, neuropathic, ophthalmic, nutraceutical, nutritional, probiotic, prebiotic, homeopathic, gastroenterological, immunological, otorhinolaryngological, cardiovascular, dermatological and oral hygiene products, namely, pharmaceutical preparations for the treatment of musculo-skeletal disorders and for the treatment of infectious diseases, pain, inflammation and cognitive disorders; nutritional, mineral, dietetic, nutraceutical, vitamin, antioxidants supplements; homeopathic supplements and dietetic food preparations for medical purposes, namely, vitamins adapted for pharmaceutical use; enzyme and protein dietary supplements, namely, vegetarian additives; dietary supplements for individuals with special dietary requirements, namely, vitamins; herbal dietary supplements for persons with special dietary requirements, namely, vegetarian supplements; dietary supplement drinks containing magnesium, iron; nutritional supplements for medical purposes, namely, dietetic food supplements; dietary supplements for human consumption; food and dietetic food namely food and dietetic food for babies in the nature of pills and bars; cultures of microorganisms for medical purposes; cultures of saprophytic bacteria for medical purposes; preparations of microorganisms for medical purposes

Industrial chemicals; chemical raw materials for the formulation of pharmaceuticals for humans and animals; chemical raw materials for the formulation of dietetic food, namely, dietetic food not adapted for medical purposes, dietetic food adapted for babies, preparations for dietetic food adapted for medical purposes, dietetic substances adapted for medical purposes, dietetic substances adapted for babies, food for babies; chemical raw materials for the formulation of dietetic supplements and dietetic preparations, namely, dietary supplements for dietetic purposes, for medical and non-medical purposes, dietetic supplements for medical and non-medical purposes, dietetic dietary supplements, medicated dietetic preparations and preparations for use as food additives for humans; cultures of microorganisms other than for medical purposes, namely, microorganisms for use in food and pharmaceutical manufacture; cultures of saprophytic bacteria other than for medical use; preparations of microorganisms other than for medical use, namely, microorganisms for use in food and pharmaceutical manufacture; preparations of cultures of saprophytic bacteria other than for medical purposes; bacterial substances for industrial use, namely, for medical purposes; bacteria for use in food manufacture; probiotic bacteria for the food industry for use in food manufacture; bacterial preparations for the food industry; bacterial cultures for the food industry for use in food and pharmaceutical manufacture; milk ferments and bacterial preparations used in making foodstuffs; antioxidants, fatty acids, proteins, enzymes, liposomes, cultures of microorganisms, bacteria used in making lactic acid and probiotic compositions, all used in making pharmaceuticals, dietetic compounds for humans, food for babies, food supplements, nutritional supplements, dietetic supplements, food supplements for medical purposes and dietetic food; preparations of probiotic bacteria not for medical purposes; enzymes and additives, namely, chemical enzymes and additives for use in fermentation; fermentation extracts for industrial purposes, namely, fermentation extracts for use in food manufacture; cultures of microorganism, other than for medical and veterinary use

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 16, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 30, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 29, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 29, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 29, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 12, 2025 FICR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 10, 2025 CORN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 12, 2024 TROA
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 1, 2024 CRCV
REFUSAL PROCESSED BY IB
Sep 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 6, 2024 RFCS
REFUSAL PROCESSED BY MPU
Sep 6, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 5, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 4, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 23, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 22, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 22, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 22, 2024 REPR